Female and male subjects were enrolled in a single site pilot study on facial erythema. Subjects were seen at baseline, week 4, and week 8. The dermatologist investigator and subjects assessed efficacy and tolerability at each visit on a 5 point ordinal scale.
Photographs were taken of all subjects at baseline, week 4, and week 8 with the Visia CR 4.3 using standard lighting 1 and cross polarized light of the central, right, and left face. Noninvasive erythema assessments of the face were conducted using a colorimeter and dermaspectrophotometer at baseline, week 4, and week 8.
Detailed images of subject's skin captured with cross polarized light.
Skin Redness
- 96% of subjects were observed by MD for improvement
- 44% average redness improvement
Skin Radiance
- 100% of subjects were observed by MD for improvement
- 39% average radiance improvement
Visual Roughness
- 92% of subjects were observed by MD for improvement
- 37% average visual roughness improvement
Tactile Roughness
- 88% of subjects were observed by MD for improvement
- 35% average tactile roughness improvement
Overall Complexion
- 72% of subjects were observed by MD for improvement
- 39% average complexion improvement
Study conducted July-August, 2022.
